Ultragenyx Pharmaceutical

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.

About RARE

Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza.

CEO

Emil D. Kakkis

CEOEmil D. Kakkis

Employees

1,276

Employees1,276

Headquarters

Novato, California

HeadquartersNovato, California

Founded

2010

Founded2010

Employees

1,276

Employees1,276

RARE Key Statistics

Market cap

3.54B

Market cap3.54B

Price-Earnings ratio

-5.36

Price-Earnings ratio-5.36

Dividend yield

—

Dividend yield—

Average volume

842.76K

Average volume842.76K

High today

$43.80

High today$43.80

Low today

$41.81

Low today$41.81

Open price

$42.77

Open price$42.77

Volume

1.09M

Volume1.09M

52 Week high

$54.98

52 Week high$54.98

52 Week low

$31.52

52 Week low$31.52

RARE News

Yahoo Finance 3d

Here's What Analysts Are Forecasting For Ultragenyx Pharmaceutical Inc. After Its First-Quarter Results - Yahoo Finance

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) just released its latest first-quarter report and things are not looking great. It was a pretty negative result ove...

Yahoo Finance 4d

Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update - Yahoo Finance

Ultragenyx Pharmaceutical Inc. First quarter total revenue of $109 million, Crysvita® revenue of $83 million and Dojolvi® revenue of $16 million Reaffirmed...

Analyst ratings

90%

of 21 ratings

Buy

90.5%

Hold

9.5%

Sell